Demo byMojo LayersDemo site, a fictional business, built from our Meridale Pharmaceuticals templateUse this template

Skip to content

MeridalePharmaceuticals · Toowoomba Contact

MeridaleInvestors

Investor centre

Announcements, as they're lodged.

Market announcements, reports and presentations, key dates and governance. Figures on this page are illustrations for the template.

MDLListing code (fictional)Ordinary shares

412.6mshares on issueAt 31 October

18.4$mrevenue, FY26Up from $11.2m

2,350shareholdersAt 30 June

Announcements

8 announcements

12 Nov 2026Second GMP manufacturing suite approvedPrice sensitivePDF · 380 KB
29 Oct 2026Quarterly activities and cash flow report, September quarterPDF · 1.1 MB
2 Oct 2026Annual general meeting: notice and proxy formPDF · 640 KB
27 Aug 2026Full-year results and annual reportPrice sensitivePDF · 4.8 MB
30 Jul 2026Quarterly activities and cash flow report, June quarterPDF · 1.0 MB
14 May 2026Supply agreement with national pharmacy wholesalerPrice sensitivePDF · 290 KB
20 Nov 2025Results of annual general meetingPDF · 180 KB
28 Aug 2025Full-year results and annual reportPrice sensitivePDF · 4.2 MB

Reports and presentations

The long form.

Annual reportFY2026 annual reportPDF · 4.8 MB · 27 Aug 2026 PresentationFull-year results presentationPDF · 2.2 MB · 27 Aug 2026 Half-yearHalf-year report, December 2025PDF · 1.9 MB · 26 Feb 2026

Key dates

Quarterly report, December quarter	29 Jan 2027
Half-year results	25 Feb 2027
Quarterly report, March quarter	29 Apr 2027
Full-year results	26 Aug 2027

Governance

Corporate governance statementPDF · 2026
Board and committee chartersPDF · 2026
Securities trading policyPDF · 2025
Whistleblower policyPDF · 2025

Demo website designed and built by Mojo Layers. Want one like it? Use this template